
MRNA vs VIR
$MRNA vs $VIR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MRNA vs VIR: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·VIR is the weaker of the two on trend, below both its 50- and 200-day averages, while MRNA has held above one of them.
- ·Both beat the market over the past year: MRNA +690% and VIR +66.4%, against the S&P 500 at +10.6%.
- ·The last month has flipped the order: VIR has held up better over the month (-14.8% against -18.7%) even though MRNA leads over the year.
- ·MRNA sits closer to its support, 6.7% above it at $179.56, while VIR is 33.6% above its own at $6.24.
- ·VIR is within 2% of resistance at $9.58, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
MRNA vs VIR: the quick read
- ·MRNA is the larger company by market cap ($83.68B vs $1.58B).
- ·MRNA has been more active on our scanner (341 vs 161 alerts in 30 days).
- ·VIR has the smaller float (154.7M vs 360.3M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·VIR trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 341 and 161 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: MRNA is more than 53x the market cap of VIR, so the same dollar of news moves VIR far harder.
- ·VIR pays a dividend and MRNA does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: VIR is outperforming the other by roughly 8.4 percentage points on the session.
Objective differences only. Not investment advice.
Watching MRNA or VIR? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MRNA and VIR on TheDesperateTrader.
- Is MRNA or VIR the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($83.68B vs $1.58B). MRNA has been more active on our scanner (341 vs 161 alerts in 30 days). VIR has the smaller float (154.7M vs 360.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MRNA and VIR?
- The differences that matter: MRNA is roughly 53x the size of the other by market cap ($83.68B vs $1.58B); they trade at very different share prices ($192.47 vs $9.39); MRNA sits at 66% of its 52-week range against 45% for VIR; only VIR pays a dividend; our scanner flagged MRNA 341 times in the last 30 days against 161 for VIR. Everything above is measured from the latest completed session and SEC filings.
- Which of MRNA and VIR is more active right now?
- Right now MRNA is at about 0.5x its normal volume and VIR is at about 1.3x, so VIR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is MRNA or VIR in the stronger trend?
- MRNA is below its 50-day average of $205.61 and above its 200-day average of $98.86; VIR is below its 50-day average of $11.04 and below its 200-day average of $9.79. MRNA leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MRNA or VIR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MRNA and VIR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.